Autoantibody formation in human and rat studies of chronic rejection and primary graft dysfunction
- PMID: 21925897
- PMCID: PMC3873136
- DOI: 10.1016/j.smim.2011.08.020
Autoantibody formation in human and rat studies of chronic rejection and primary graft dysfunction
Abstract
Lung transplantation is considered a definitive treatment for many lung diseases. However, rejection and other pathologic entities are major causes of morbidity and mortality for lung transplant recipients. Primary graft dysfunction (PGD) and obliterative bronchiolitis (OB) are the leading causes of early and late mortality, respectively. While the immune basis of PGD has not been clearly defined, evidence is emerging about roles for autoantibodies in this process. Similarly, the pathogenesis of OB has been linked recently to autoimmunity. This review will highlight the current understanding of autoantibodies in PGD and OB post lung transplantation.
Copyright © 2011 Elsevier Ltd. All rights reserved.
References
-
- Kotloff RM, Thabut G. Lung transplantation. Am J Respir Crit Care Med. 2011;184:159–171. - PubMed
-
- Verleden GM. Chronic allograft rejection (obliterative bronchiolitis) Semin Respir Crit Care Med. 2001;22:551–558. - PubMed
-
- Verleden GM, Vos R, De Vleeschauwer SI, Willems-Widyastuti A, Verleden SE, Dupont LJ, Van Raemdonck DE, Vanaudenaerde BM. Obliterative bronchiolitis following lung transplantation: from old to new concepts? Transpl Int. 2009;22:771–779. - PubMed
-
- Lee JC, Christie JD. Primary graft dysfunction. Proc Am Thorac Soc. 2009;6:39–46. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
